305 Broadway,7th Floor
10007 New York City, us
+1 (646) 568-7751
Proton Therapy Market Anticipated to Surpass US$ 3 Bn by 2024
Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12358
The effectiveness of proton therapy continues to gain trust of cancer patients across the globe. The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor. Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments. Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2024, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.
Request to view table of content @ http://www.persistencemarketresearch.com/market-research/proton-therapy-systems-market/toc
Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europe’s proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR. The report has also profiled leading players in the global proton therapy market, which include Hitachi Ltd., Mitsubishi Electric Corporation, Varian Medical Systems, Sumitomo Heavy Industries Ltd., ProTom International, Mevion Medical Systems, Ion Beam Applications SA, and ProNova Solutions, LLC.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/proton-therapy-systems-market.asp
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.